MCG7 Capital Inc.
Known title: 10% OwnerCIK: 0001894090
Associated companies
Transaction History
| BRZE | ▼ Sell | Other | 4,278,960 | — | 11/13/2024 | View on chart |
| BRZE | ▼ Sell | Other | 355,448 | — | 11/7/2022 | View on chart |
| BRZE | ▼ Sell | Other | 355,448 | — | 11/7/2022 | View on chart |
| BRZE | ▼ Sell | Other | 1,000,000 | — | 11/4/2022 | View on chart |
| BRZE | ▼ Sell | Other | 1,000,000 | — | 9/19/2022 | View on chart |
| BRZE | ▼ Sell | Other | 2,000,000 | — | 4/11/2022 | View on chart |
| BRZE | ▼ Sell | Other | 634,408 | — | 11/19/2021 | View on chart |
| BRZE | ▼ Sell | Other | 8,634,408 | — | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Braze Shares Rise Amid Analyst Support and Valuation Focus
Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.
Braze Shares Rise Amid Analyst Support and Valuation Focus. Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.